Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 10, 2024

SELL
$154.79 - $180.76 $44,889 - $52,420
-290 Reduced 0.73%
39,347 $6.75 Million
Q1 2024

Apr 11, 2024

SELL
$159.82 - $182.1 $7,351 - $8,376
-46 Reduced 0.12%
39,637 $7.22 Million
Q4 2023

Jan 10, 2024

SELL
$137.6 - $154.97 $34,537 - $38,897
-251 Reduced 0.63%
39,683 $6.15 Million
Q3 2023

Oct 10, 2023

SELL
$133.59 - $154.65 $68,398 - $79,180
-512 Reduced 1.27%
39,934 $5.95 Million
Q2 2023

Jul 12, 2023

SELL
$132.51 - $164.9 $795 - $989
-6 Reduced 0.01%
40,446 $5.45 Million
Q1 2023

Apr 11, 2023

SELL
$144.61 - $166.54 $11,568 - $13,323
-80 Reduced 0.2%
40,452 $6.45 Million
Q4 2022

Jan 12, 2023

SELL
$138.31 - $165.87 $691 - $829
-5 Reduced 0.01%
40,532 $6.55 Million
Q3 2022

Oct 13, 2022

SELL
$134.21 - $153.93 $2,684 - $3,078
-20 Reduced 0.05%
40,537 $5.44 Million
Q2 2022

Jul 15, 2022

SELL
$137.62 - $174.96 $11,009 - $13,996
-80 Reduced 0.2%
40,557 $6.21 Million
Q1 2022

Apr 12, 2022

SELL
$131.98 - $163.75 $8,446 - $10,480
-64 Reduced 0.16%
40,637 $6.59 Million
Q4 2021

Jan 21, 2022

SELL
$107.43 - $135.93 $4.37 Million - $5.53 Million
-40,701 Reduced 50.0%
40,701 $5.51 Million
Q4 2021

Jan 12, 2022

BUY
$107.43 - $135.93 $4.33 Million - $5.48 Million
40,291 Added 98.01%
81,402 $11 Million
Q3 2021

Oct 12, 2021

SELL
$106.4 - $120.78 $21,280 - $24,156
-200 Reduced 0.48%
41,111 $4.44 Million
Q1 2021

Apr 08, 2021

SELL
$102.3 - $112.62 $98,514 - $108,453
-963 Reduced 2.28%
41,311 $4.47 Million
Q4 2020

Jan 13, 2021

BUY
$80.49 - $108.67 $12,717 - $17,169
158 Added 0.38%
42,274 $4.53 Million
Q3 2020

Oct 07, 2020

SELL
$85.91 - $100.83 $97,507 - $114,442
-1,135 Reduced 2.62%
42,116 $3.69 Million
Q2 2020

Jul 08, 2020

SELL
$73.37 - $98.18 $83,274 - $111,434
-1,135 Reduced 2.56%
43,251 $4.25 Million
Q1 2020

Apr 08, 2020

BUY
$64.5 - $97.79 $2.86 Million - $4.34 Million
44,386 New
44,386 $3.38 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Foundation Resource Management Inc Portfolio

Follow Foundation Resource Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Foundation Resource Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Foundation Resource Management Inc with notifications on news.